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Abstract: Objectives: Survivors of critical illness have an increased incidence of bone fractures.
However, early changes in bone strength, and their relationship to structural changes,
have not been described. We aimed to characterize early changes in bone functional
properties in critical illness and their relationship to changes in bone structure, using a
sepsis rodent model.
Design: Experimental Study
Setting: Animal Research Laboratory
Subjects: Adult Sprague-Dawley rats
Interventions: Forty Sprague-Dawley rats were randomised to cecal ligation and
puncture (CLP) or sham surgery. Twenty rodents (10 CLP, 10 sham) were sacrificed at
24 hours, and 20 more at 96 hours.
Measurements and main results: Femoral bones were harvested for strength testing,
microCT imaging, histological analysis, and multi-frequency scanning probe
microscopy (SPM). Fracture loads at the femoral neck were significantly reduced for
CLP-exposed rodents at 24 hours (83.39±10.1N vs. 103.1±17.6N; p=0.014) and 96
hours (81.60 ±14.2N vs. 95.66±14.3N; p=0.047). Using multi-frequency SPM, collagen
elastic modulus was lower in CLP-exposed rats at 24 hours (1.37±0.2GPa vs.
6.13±0.3GPa; p=0.001) and 96 hours (5.57±0.5GPa vs. 6.13±0.3GPa; p=0.006). Bone
mineral elastic modulus was similar at 24 hours, but reduced in CLP-exposed rodents
at 96 hours (75.34±13.2GPa vs. 134.4± 8.2GPa; p<0.001). There were no bone
architectural or Bone Mineral Density differences by microCT. Similarly, histological
analysis demonstrated no difference in collagen and, elastin staining, and Chemokine
Receptor type 4, Nuclear Factor Kappa Beta and Tartarate Resistant Acid
Phosphatase immunostaining.
Conclusions: In a rodent sepsis model, trabecular bone strength is functionally reduced
within 24 hours and is associated with a reduction in collagen and mineral elastic
modulus. This is likely to be the result of altered biomechanical properties, rather than
increased bone mineral turnover. These data offer both mechanistic insights and may
potential guide development of therapeutic interventions.
Response to Reviewers: Reply to Reviewers: Sepsis reduces bone strength
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
Reviewer 1: This experimental study adds laboratory based evidence to the emerging
literature on increased bone turnover, loss of bone density, and fracture after critical
illness. The comparison of 20 rats undergoing cecal ligation to 20 with sham surgery,
and analysing femoral bone strength using microCT, microscopy, and histological
analysis is original and interesting. The findings of reduced fracture load, lower
collagen elastic modulus, bone mineral elastic modulus, but no difference in BMD or
bone architecture as measured by microCT, are interesting. Overall these results
suggest early mechanisms other than loss of BMD may be important in critical illness,
a plausible theory, particularly given the aetiology, risk factors, mechanisms, time
course, and impact of altered bone health after critical illness remains largely
unexplored.
Also, this study adds to the existing population based literature as there is a lack of
microscopic or histological data exploring mechanisms of abnormal bone health after
critical illness. As the authors point out it is difficult to obtain this in human, so
laboratory data is vital. These results could lead to further research in longer term
changes in bone morphology observed over time (i.e. do early changes result in
microarchitectural change along term), and the effects of targeted interventions.
Many thanks for your kind words regarding our data. These data will indeed form the
basis of interventional studies.
Reviewer 2: This is an animal study exploring an important area of emerging interest
and provides some insights into the mechanism of early skeletal perturbations in
critical illness providing a basis for further clinical studies.
It builds on recent work around the role of bone in the syndrome of critical illness. Their
findings that bone architecture and BMD remained unchanged and there was no
histological changes challenge some of the current understanding of the subject and
merit further study.
The authors have adequately addressed reviewers' comments.
Thank you.
Reviewer 3:
C1: Overall I think this is a valuable and novel piece of literature. In my opinion, the
authors have adequately address the comments from the first revision.
Thank you.
C2: How did the authors choose the sample size for the study and was a primary
outcome selected a priori? I understand that it is not as "standard" for animal studies to
consider this during the design. That said, animal studies suffer the same risks as
human studies with respect to being underpowered to show differences and reporting
bias. Along these same lines the authors should be careful in their wording about what
they were able to prove as "Statistically different" vs. what appeared to be big
difference between groups, but where they did not have adequate sample to show
statistical difference given either measurement error or significant within animal
variability (large SDs). They provide a long list of "not different" things in the discussion
- The chance for type II error (in addition to type I) error is significant given the sample
size.
We completely agree with the reviewer’s comments re differences and reporting bias.
Further, the chance of a type II error was not addressed, and we have added a
paragraph to the discussion under limitations:
“Whilst no formal power calculation was performed, AFM scanning microscopy
comparing bone stiffness in wild-type mice to those with osteogenesis imperfecta, has
detected significant differences using a sample size of 21. We expected a larger
standard deviation in our CLP group, therefore a larger sample size was selected,
consistent with other animal publications in critical illness2-4. Despite this, in humans
patchy myonecrosis has been seen affecting different areas of muscle5- if the same
were true for bone, histological and immunostaining data reported in this manuscript
may be at risk of a Type II error.”
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C3: I also wonder whether the authors should consider whether the animal model is
truly one of "critical illness". Based upon the description provided in the methods and
results it could be argued that the animals were not that unwell - they received minimal
support following CLP and all lived. What would be expected when compared to other
CLP papers? The fact all the animals lived should be discussed (at least in the
limitations section). In my opinion some attention to this may support, instead of
undermine, the importance of the findings. If the authors were able to identify
significant functional changes on a model of "mild/moderate" critical illness, one can
only imagine the differences they would have shown in a model where the animals
were sick enough to require intubation, vasopressors, renal replacement, etc.
Thank you for this highly constructive comment. We have added:
“The CLP model used had a 0% rate of mortality, unlike the 55% reported in other 50%
caecal ligation studies6. Therefore, this model is more likely to represent a
mild/moderate form of critical illness. Models with higher mortality and end-organ
damage (perhaps more representative of the higher acuity spectrum of critical illness)
may demonstrate greater loss of elastic modulus and bone strength.”
C4: 3. How did the authors choose 24 and 96 hours? Can they provide a justification?
Is this long enough to expect to see changes (BMD and microarchitecture).
We thank the reviewer for this useful comment. 96 hours was chosen for two reasons.
First, we were principally interested in early bone changes during critical illness.
Second, we actually expected mortality to approach 50 by 96 hours in the CLP group6.
Therefore, we would have needed many more rodents in the CLP group to extend the
study beyond 96 hours. We have added the following to the discussion to address this
comment.
“Our animals were sacrificed at 96 hours, and it is possible insufficient time elapsed to
accumulate changes in BMD or microarchitecture. However, rodent metabolic and
muscle changes can be detected within this time frame7, and our hypothesis is
focused on identifying bone changes in early critical illness, where interventions could
modulate bone health in survivors.”
C5: 4. All of the above factors intersect to work against the authors. Small sample size
+ non-critically ill animal model + limited time frame for outcome evaluation following
insult. Again, this may work to the advantage of the authors as despite this they do
show some interesting differences. These problems could be discussed in greater
depth and framed in a light to support the need for larger studies on animal models or
humans where it is possible to induce true critical illness requiring intervention, and is
long lasting.
Thank you again for this constructive comment. We have added the following to the
discussion, incorporating the response to comment 1:
“Despite the lower acuity and limited time frame, differences in elastic modulus and
bone strength were demonstrated. Whilst no formal power calculation was performed,
AFM scanning microscopy comparing bone stiffness in wild-type mice to those with
osteogenesis imperfecta, detected significant differences using a sample size of 21.
We expected a larger standard deviation in our CLP group, therefore a larger sample
size was selected, consistent with other animal publications in critical illness2-4.
Despite this, in humans, patchy myonecrosis has been seen affecting different areas of
muscle5- if the same were true for bone, histological and immunostaining data
reported in this manuscript may be at risk of a Type II error. Our data suggest the need
for larger studies on animal models (induced with a higher acuity of critical illness) or
human subjects where sustainable interventions can be additionally be assessed.”
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Reviewer 1: This experimental study adds laboratory based evidence to 
the emerging literature on increased bone turnover, loss of bone 
density, and fracture after critical illness. The comparison of 20 rats 
undergoing cecal ligation to 20 with sham surgery, and analysing 
femoral bone strength using microCT, microscopy, and histological 
analysis is original and interesting. The findings of reduced fracture 
load, lower collagen elastic modulus, bone mineral elastic modulus, 
but no difference in BMD or bone architecture as measured by 
microCT, are interesting. Overall these results suggest early 
mechanisms other than loss of BMD may be important in critical 
illness, a plausible theory, particularly given the aetiology, risk factors, 
mechanisms, time course, and impact of altered bone health after 
critical illness remains largely unexplored. 
 
Also, this study adds to the existing population based literature as 
there is a lack of microscopic or histological data exploring mechanisms 
of abnormal bone health after critical illness. As the authors point out 
it is difficult to obtain this in human, so laboratory data is vital. These 
results could lead to further research in longer term changes in bone 
morphology observed over time (i.e. do early changes result in 
microarchitectural change along term), and the effects of targeted 
interventions. 
 
Many thanks for your kind words regarding our data. These data will indeed 
form the basis of interventional studies. 
 
Reviewer 2: This is an animal study exploring an important area of 
emerging interest and provides some insights into the mechanism of 
early skeletal perturbations in critical illness providing a basis for 
further clinical studies. 
It builds on recent work around the role of bone in the syndrome of 
critical illness. Their findings that bone architecture and BMD remained 
unchanged and there was no histological changes challenge some of 
the current understanding of the subject and merit further study. 
The authors have adequately addressed reviewers' comments. 
 
Thank you. 
 
Reviewer 3: 
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C1: Overall I think this is a valuable and novel piece of literature. In my 
opinion, the authors have adequately address the comments from the 
first revision. 
 
Thank you. 
 
C2: How did the authors choose the sample size for the study and was 
a primary outcome selected a priori? I understand that it is not as 
"standard" for animal studies to consider this during the design. That 
said, animal studies suffer the same risks as human studies with 
respect to being underpowered to show differences and reporting bias. 
Along these same lines the authors should be careful in their wording 
about what they were able to prove as "Statistically different" vs. what 
appeared to be big difference between groups, but where they did not 
have adequate sample to show statistical difference given either 
measurement error or significant within animal variability (large SDs). 
They provide a long list of "not different" things in the discussion - The 
chance for type II error (in addition to type I) error is significant given 
the sample size. 
 
We completely agree with the reviewer’s comments re differences and 
reporting bias. Further, the chance of a type II error was not addressed, 
and we have added a paragraph to the discussion under limitations: 
 
“Whilst no formal power calculation was performed, AFM scanning 
microscopy comparing bone stiffness in wild-type mice to those with 
osteogenesis imperfecta, has detected significant differences using a 
sample size of 21. We expected a larger standard deviation in our CLP 
group, therefore a larger sample size was selected, consistent with other 
animal publications in critical illness2-4. Despite this, in humans patchy 
myonecrosis has been seen affecting different areas of muscle5- if the 
same were true for bone, histological and immunostaining data reported 
in this manuscript may be at risk of a Type II error.” 
 
C3: I also wonder whether the authors should consider whether the 
animal model is truly one of "critical illness". Based upon the 
description provided in the methods and results it could be argued that 
the animals were not that unwell - they received minimal support 
following CLP and all lived. What would be expected when compared 
to other CLP papers? The fact all the animals lived should be discussed 
(at least in the limitations section). In my opinion some attention to 
this may support, instead of undermine, the importance of the 
findings. If the authors were able to identify significant functional 
changes on a model of "mild/moderate" critical illness, one can only 
imagine the differences they would have shown in a model where the 
animals were sick enough to require intubation, vasopressors, renal 
replacement, etc. 
 
Thank you for this highly constructive comment. We have added: 
 
“The CLP model used had a 0% rate of mortality, unlike the 55% reported 
in other 50% caecal ligation studies6. Therefore, this model is more likely 
to represent a mild/moderate form of critical illness. Models with higher 
mortality and end-organ damage (perhaps more representative of the 
higher acuity spectrum of critical illness) may demonstrate greater loss 
of elastic modulus and bone strength.” 
 
C4: 3. How did the authors choose 24 and 96 hours? Can they provide a 
justification? Is this long enough to expect to see changes (BMD and 
microarchitecture). 
 
We thank the reviewer for this useful comment. 96 hours was chosen 
for two reasons. First, we were principally interested in early bone 
changes during critical illness. Second, we actually expected mortality to 
approach 50 by 96 hours in the CLP group6. Therefore, we would have 
needed many more rodents in the CLP group to extend the study 
beyond 96 hours. We have added the following to the discussion to 
address this comment. 
 
“Our animals were sacrificed at 96 hours, and it is possible insufficient 
time elapsed to accumulate changes in BMD or microarchitecture. 
However, rodent metabolic and muscle changes can be detected within 
this time frame7, and our hypothesis is focused on identifying bone 
changes in early critical illness, where interventions could modulate bone 
health in survivors.” 
 
C5: 4. All of the above factors intersect to work against the authors. 
Small sample size + non-critically ill animal model + limited time frame 
for outcome evaluation following insult. Again, this may work to the 
advantage of the authors as despite this they do show some 
interesting differences. These problems could be discussed in greater 
depth and framed in a light to support the need for larger studies on 
animal models or humans where it is possible to induce true critical 
illness requiring intervention, and is long lasting. 
 
Thank you again for this constructive comment. We have added the 
following to the discussion, incorporating the response to comment 1: 
 
“Despite the lower acuity and limited time frame, differences in elastic 
modulus and bone strength were demonstrated. Whilst no formal power 
calculation was performed, AFM scanning microscopy comparing bone 
stiffness in wild-type mice to those with osteogenesis imperfecta, 
detected significant differences using a sample size of 21. We expected a 
larger standard deviation in our CLP group, therefore a larger sample 
size was selected, consistent with other animal publications in critical 
illness2-4. Despite this, in humans, patchy myonecrosis has been seen 
affecting different areas of muscle5- if the same were true for bone, 
histological and immunostaining data reported in this manuscript may 
be at risk of a Type II error. Our data suggest the need for larger studies 
on animal models (induced with a higher acuity of critical illness) or 
human subjects where sustainable interventions can be additionally be 
assessed.” 
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Abstract 1 
Objectives: Survivors of critical illness have an increased incidence of bone fractures. 2 
However, early changes in bone strength, and their relationship to structural changes, 3 
have not been described. We aimed to characterize early changes in bone functional 4 
properties in critical illness and their relationship to changes in bone structure, using a 5 
sepsis rodent model.   6 
Design: Experimental Study 7 
Setting: Animal Research Laboratory 8 
Subjects: Adult Sprague-Dawley rats 9 
Interventions: Forty Sprague-Dawley rats were randomised to cecal ligation and 10 
puncture (CLP) or sham surgery. Twenty rodents (10 CLP, 10 sham) were sacrificed 11 
at 24 hours, and 20 more at 96 hours. 12 
Measurements and main results: Femoral bones were harvested for strength testing, 13 
microCT imaging, histological analysis, and multi-frequency scanning probe 14 
microscopy (SPM). Fracture loads at the femoral neck were significantly reduced for 15 
CLP-exposed rodents at 24 hours (83.39±10.1N vs. 103.1±17.6N; p=0.014) and 96 16 
hours (81.60 ±14.2N vs. 95.66±14.3N; p=0.047). Using multi-frequency SPM, 17 
collagen elastic modulus was lower in CLP-exposed rats at 24 hours (1.37±0.2GPa vs. 18 
6.13±0.3GPa; p=0.001) and 96 hours (5.57±0.5GPa vs. 6.13±0.3GPa; p=0.006). Bone 19 
mineral elastic modulus was similar at 24 hours, but reduced in CLP-exposed rodents 20 
at 96 hours (75.34±13.2GPa vs. 134.4± 8.2GPa; p<0.001). There were no bone 21 
architectural or Bone Mineral Density differences by microCT. Similarly, histological 22 
analysis demonstrated no difference in collagen and, elastin staining, and Chemokine 23 
Receptor type 4, Nuclear Factor Kappa Beta and Tartarate Resistant Acid Phosphatase 24 
immunostaining.  25 
 4 
Conclusions: In a rodent sepsis model, trabecular bone strength is functionally 1 
reduced within 24 hours and is associated with a reduction in collagen and mineral 2 
elastic modulus. This is likely to be the result of altered biomechanical properties, 3 
rather than increased bone mineral turnover. These data offer both mechanistic 4 
insights and may potential guide development of therapeutic interventions. 5 
  6 
 5 
INTRODUCTION 1 
Intensive care unit (ICU) survivors suffer from a variety of cognitive, neurological 2 
and physical impairments, which persist beyond acute care hospitalization and have 3 
been described as the “Post-Intensive Care Syndrome” (PICS) (1).  Bone health is 4 
likely to be an important component of PICS (2), and population studies have 5 
demonstrated a higher incidence of bone fractures in patients discharged from ICU 6 
(3). Subsequent studies, seeking mechanistic explanations, have demonstrated 7 
reduced bone mineral density (BMD) in ICU survivors (4, 5). However, it remains 8 
unclear whether the observed BMD changes, and increased fracture incidence, result 9 
from the direct effects of critical illness, prolonged immobility, or both (6). 10 
 11 
Although it is clearly established that prolonged immobility contributes to much 12 
neuromuscular morbidity in ICU survivors (7, 8), it is also apparent that metabolic 13 
derangements and cytokinaemia in early critical illness play a pivotal role (9, 10). 14 
Similarly, critically ill patients are exposed to a variety of insults that may rapidly 15 
compromise bone structure and composition, such as inflammation, acidaemia, 16 
vitamin D deficiency, corticosteroid use and hypoxia (5). These adverse stimuli may 17 
result in structural changes, or alterations in bone turnover mediated by upregulation 18 
of pathways affecting osteoblastogenesis (11) or osteclastogenesis (12), or a 19 
combination. Therefore, bone health during, or following, critical illness may be the 20 
result of a number of factors, and complete understanding is likely to include 21 
mechanisms other than accumulated loss of BMD. 22 
 23 
Factors beyond BMD certainly influence bone strength and susceptibility to fracture 24 
(13). Indeed, bone displays a hierarchical organization in its structure and 25 
 6 
composition, ranging from macroscopic to molecular scales. Other, important, 1 
components of bone morphology influencing bone strength include bone size, cortical 2 
thickness and moment of inertia (14). In addition to whole bone morphology, bone 3 
microarchitecture, such as trabeculae shape and cortical porosity, as well as tissue 4 
properties, including collagen cross-linking and hydration, play important roles in 5 
bone strength. As a result, qualitative changes in bone strength and mechanical 6 
properties, independent of BMD, are well recognized (14).  7 
 8 
We hypothesized that critical illness results in early, functionally significant, changes 9 
in bone strength. Since invasive bone studies are not feasible in critically ill patients 10 
(15), we used a rodent model of sepsis to investigate the effects of systemic sepsis and 11 
inflammation on mechanical bone strength; nearly 40% of critically ill patients 12 
admitted to the intensive care unit (ICU) are affected by sepsis (16). In addition, we 13 
conducted a histomorphometric analysis to identify macro- and microscopic 14 
perturbations  that may offer mechanistic insight. 15 
 16 
METHODS 17 
Expanded methods available in online supplement. 18 
Rat sepsis model 19 
After obtaining Institutional Animal Care and Use Committee approval, 40 male 20 
Sprague-Dawley rats were randomized to receive cecal ligation and puncture (CLP) 21 
or sham surgery. In CLP rodents, 50% of the cecum was ligated and the anterior and 22 
posterior walls puncture with an 18G needle in a single pass  (17). In sham rodents, 23 
cecum was mobilized and replaced. Following surgery, rats were given subcutaneous 24 
fluid and analgesia and returned to individual cages with food ad libitum. After 24 25 
 7 
and 96 hours, 10 rats in each group were euthanized with carbon dioxide inhalation 1 
and femur bones harvested. Non-invasive imaging was performed prior to strength 2 
testing. 3 
 4 
Bone mechanical testing 5 
Prior to testing biomechanical properties, bone dimensions were measured used a 6 
Vernier calliper. 7 
 8 
Three-point bending test: To measure cortical bone biomechanical properties, the 9 
right femur underwent a 3-point bending analysis. Each bone sample was placed 10 
horizontally on two transverse supports (span length (L) 17mm) with the anterior 11 
surface facing up. Load was applied perpendicularly to the bone till fracture at a 12 
constant rate of 5mm/min, using a materials testing machine, Instron-5543 (Instron 13 
Corp, Canton MA, USA). The parameters measured were load at break (N), Young’s 14 
modulus (MPa), flexure stress at maximum load (MPa) and flexure strain (extension) 15 
at maximum load (mm/mm) normalized to outer thickness of bone.    16 
 17 
Femoral neck break: To measure trabecular bone biomechanical properties, the femur 18 
underwent a femur neck break analysis. Following the 3-point bending test, samples 19 
were potted using dental cement and the length of neck and angle (Radian) measured. 20 
Samples were clamped down and a vertical load, using a flat-surface arrow-head 21 
cylinder (Instron 5543, Instron Corp, Canton MA, USA), was applied at the top of the 22 
femoral head parallel to the axis of its diaphysis at a constant rate of 5mm/min till 23 
fracture. Parameters measured were maximum Load (N), Young’s modulus (N/mm), 24 
 8 
compression component (N), bending component (N) and bending momentum (N-1 
mm). 2 
 3 
Assessment of bone nano-mechanics  4 
Femurs were cleaned, sectioned, air dried, embedded in epoxy resin, mechanically 5 
polished and placed on microscope slides. AM-FM (amplitude modulation-frequency 6 
modulation) multi-frequency scanning probe microscopy (SPM)  was then performed 7 
(18).  8 
 9 
An oscillating sharpened probe (connected to a cantilever) was moved over the 10 
sample surface. Bone surface topography was mapped by cantilever movement, with 11 
the spring-like action of the cantilever allowing force measurements to be performed 12 
(19). The SPM probe was excited at two eigen-frequencies. The first eigenmode 13 
amplitude was used to image surface topography and the second eigenmode resonant 14 
frequency shift was used to map contact stiffness (20). Twenty measurements were 15 
taken from each bone sample (10 collagen, 10 mineral) with the average presented as 16 
a single data point for modulus in each sample.  17 
 18 
Micro-computed tomography measurements 19 
Femurs were scanned ex vivo using a Quantum GX micro-computerised tomography 20 
(microCT) imaging system (PerkinElmer, Waltham, Massachusetts, United States). 21 
Images were analysed at 3 locations, both at the shaft and neck, for bone volume/total 22 
volume (%), trabecular thickness (mm), trabecular separation (mm), connectivity 23 
density (mm-3), degree of anisotropy (DA) and bone mineral density, (BMD) (g/mm3) 24 
using BoneJ software (21). 25 
 9 
 1 
Bone histomorphometry 2 
Bones were measured using a Vernier caliper and then prepared for histological 3 
staining. Slides were stained with hemotoxylin and eosin, Masson’s trichrome stain 4 
(for collagen) and Verhoeff stain (for elastin). The total number of osteoblasts within 5 
a specified area on either side of the fracture was manually counted and a proportion 6 
checked by an independent blinded histopathologist. Verhoeff and Masson trichrome 7 
stained areas were analyzed using ImageJ (22) and results expressed as a percentage 8 
of total bone area. 9 
 10 
Immunohistochemistry was performed on deparaffinized bone sections using 11 
the appropriate primary and secondary antibodies; tartrate-resistant acid 12 
phosphatase (TRAP) [ab58008] and Cysteine (C)-X-C motif chemokine receptor 13 
4 (CXCR4) [ab124824] (Abcam, Cambridge, Massachusetts, USA); Nuclear Factor 14 
Kappa Beta (NF-κB) [#8242] (Cell Signaling, Denver, Massachusetts, USA). 15 
Analysis was performed on tissue sections to quantify the number of positively 16 
stained cells per region of interest or per bone section using ImageJ  (22). 17 
 18 
Statistical analysis 19 
Data are presented as mean (± standard deviation) or median (interquartile range) 20 
where appropriate. Differences were analyzed using one-way ANOVA with post hoc 21 
Bonferroni or Student’s t-test for parametric data and Mann Whitney U test for non-22 
parametric data. A p value <0.05 was considered significant. Levene’s statistical test 23 
was used to compare distribution (standard deviation) data of elastic moduli. 24 
 25 
 10 
RESULTS 1 
All forty rats survived to the end of the protocol. The weight at the time of surgery 2 
was similar in all four groups (300 - 350g); weight loss between both groups was not 3 
significantly different at 24 hours, but percentage weight loss was significantly greater 4 
in the CLP-exposed group at 96 hours (3.8% vs. 12.8% p < 0.01), as expected 5 
(Supplemental Digital Content-Table 1). 6 
 7 
Mechanical Bone Strength 8 
Femoral neck: The maximum load required to fracture the femoral neck was 20% less 9 
for CLP-exposed rats relative to sham control after 24 hours (83.39±10.1 Newton (N) 10 
vs. 103.1±17.6N; n=8; p=0.014). This difference persisted at 96 hours (81.60 ±14.2N 11 
vs. 95.66±14.3N; n=9; P=0.047) (Figure 1A). Compressive strength was decreased in 12 
CLP-exposed rats at 24 hours, compared to sham (44.32±5.7N vs. 58.75±14.8N; n=8; 13 
p=0.021); a similar difference was observed at 96 hours although not statistically 14 
significant (45.8±12.1N vs. 55.8±8.2N; n=8; p=0.068) (Figure 1C). Bending strength 15 
differed in CLP-exposed rats, compared to sham, although statistical significance was 16 
achieved only at 96 hours (at 24 hours: 70.49±9.6N vs. 83.87±15.9N; n=8; p=0.057; 17 
at 96 hours: 66.89±12.3N vs. 80.2±13.3N; n=8; p=0.038) (Figure 1D). 18 
 19 
Femoral shaft: There was no significant difference in the maximum load required to 20 
fracture the femoral shaft of CLP-exposed rats when compared to sham, at either 24 21 
hours (118.32±18.2N vs. 119.78±23.9N; n=10; p=0.88) or 96 hours (116.81±27.3N 22 
vs. 128.75±28.5.9N; n=8; p=0.379) (Figure 1B).  23 
 24 
 25 
 11 
Bone nano-mechanics with multi-frequency scanning probe microscopy 1 
Collagen elastic modulus was lower after 24 hours in CLP rats compared to sham 2 
(1.37±0.2 Gigapascals (GPa) vs. 6.13±0.3 GPa; n=8; p=0.001). Despite partial 3 
recovery at 96 hours, it remained lower than controls (5.57±0.5 GPa vs. 6.13±0.3 4 
GPa; n=8; p=0.006) (Figure 2A). In contrast, bone mineral elastic modulus was 5 
similar in both groups at 24 hours (128.7±8.1 GPa vs. 134.4±8.2 GPa; n=8; p=0.131), 6 
but reduced in CLP-exposed rats at 96 hours (75.34±13.2 GPa vs. 134.4±8.2 GPa; 7 
n=8; p<0.001) (Figure 2B). Representative images are shown in Figure 3A and 3B. 8 
The distributions of elastic moduli measurements for each group are shown in Figure 9 
4. Collagen elastic modulus distribution was higher at 96 hours compared to sham 10 
(Levene statistic 238.6, p<0.001; Supplementary Digital Content Figure 1A) implying 11 
impaired collagen quality recovery. The Mineral elastic modulus was similarly 12 
affected at 96 hours (Levene statistic 150.5; p<0001; Supplementary Digital Content 13 
Figure 1B). 14 
 15 
Whole bone geometry 16 
As shown in Supplemental Digital Content Table 2, there was no difference in cortical 17 
thickness, neck and shaft diameter or neck length between CLP and sham groups at 18 
24 and 96 hours. 19 
 20 
Bone mineral density and microarchitecture  21 
Micro-CT reconstruction and histomorphometric analysis of the femoral neck did not 22 
reveal differences between CLP and sham in bone volume/total volume ratio, 23 
trabecular thickness and separation, connectivity density, degree of anisotropy and 24 
 12 
bone mineral density at 24 or 96 hours (all p>0.10, Table S1). Representative images 1 
are shown in Figures 3C and 3D. 2 
 3 
Histological analysis 4 
Histologic sections demonstrated no difference in epiphyseal growth plate thickness 5 
and cellular organization between CLP-exposed and sham groups at 24 hours 6 
(118±7µM vs. 125±14µM; p=0.425) or 96 hours (115±22µM vs. 102±6µM; 7 
p=0.289). Osteoblast numbers did not differ in CLP-exposed rodents at 24 hours 8 
(2.1±0.5 vs. 2.2±0.8; p=0.758) or at 96 hours (1.8±0.4 vs. 1.7±0.6; p=0.684). 9 
Similarly, no differences were seen in TRAP staining (marker of osteoclastic 10 
differentiation) at 24 hours (17.4±6.6% vs. 16.2±4.2; p=0.803) and at 96 hours 11 
(19.9±2.5% vs. 15.9±8.0%; p=0.456). No significant differences were seen between 12 
both groups in percentage of elastin staining at 24 hours (12.9±5.5% vs. 29.1±21.0%; 13 
p=0.185) or 96 hours (34.0±22.8 vs. 14.4±4.4%; p=0. 143), and percentage of 14 
collagen staining (75.6±11.5% vs. 70.1±17% %; p=0.611) and (70.5±15.0% vs. 75.0 15 
±10.9%; p=0.638). Representative images are shown in Figure 4. 16 
 17 
CXCR4 staining did not differ between sham and CLP at 24 hours (15.2±10.3% vs. 18 
11.6±5.0%; p=0.612) or 96 hours (16.5±11.9% vs. 9.7±4.7%; p=0.407) and similarly 19 
with NF-κB at 24 hours (2.2±1.4% vs. 3.3±1.1%; p=0.325) and at 96 hours (5.1±3.3% 20 
vs. 6.9±3.9%; p=0.559). Representative images are shown in Figure 5. 21 
 22 
 23 
 24 
 25 
 13 
DISCUSSION 1 
 2 
In this study, we set out to establish the nature of bone response to critical illness, and 3 
the related functional consequences. In the CLP-exposed rodents there was evidence 4 
of early functional changes, compared to sham surgery controls, with a lower 5 
maximum load required to fracture the femoral neck at 24 hours. Multi-frequency 6 
SPM demonstrated a rapid decrease in collagen elastic modulus at 24 hours, which 7 
partially recovered at 96 hours. Mineral elastic modulus was preserved at 24 hours, 8 
but decreased significantly at 96 hours. 9 
 10 
Bone architecture and BMD remained unchanged, as determined by micro-CT. 11 
Similarly, histological analysis revealed no differences in bone structure or collagen 12 
and elastin content. The observed decrease in bone strength was not accompanied by 13 
any change in CXCR4 or NFκβ expression, or disruption in epiphyseal growth plate 14 
organization, osteoblast or osteoclast morphology or quantity and TRAP activity. The 15 
CXCR4 pathway plays a crucial role in the osteogenic differentiation of mesenchymal 16 
progenitors, and a disruption in its expression or function results in bone epiphyseal 17 
growth plate disorganization and abnormal steoblasts development (23).  The 18 
transcription factor NFκβ is a crucial mediator of inflammatory responses, and has 19 
been implicated in promoting differentiation of myeloid cells into osteoclasts to 20 
exacerbate bone resorption, and to impair bone formation by disrupting osteoblast 21 
formation and function (24).  22 
 23 
The observation of early functional changes to bone strength, in the absence of 24 
macroscopic or microscopic changes, reflect the complex organization of bone 25 
 14 
structure and the many factors contributing to bone strength. Alterations in matrix 1 
composition leading to loss of elastic modulus may effect bone strength, without 2 
changing BMD (25), but were excluded by histological analysis.  Similarly, the lack 3 
of significant pertubations in osteoblast and osteoclast quantity and epiphyseal growth 4 
plate thickness and cellular organization, does not support increased bone turnover as 5 
an explanation for the early reduction in bone strength we observed. 6 
 7 
We used multi-frequency scanning probe microscopy (SPM) to analyze changes in 8 
bone tissue properties. This technique has been used to study the nano-mechanical 9 
properties of a range of biological tissues (26-28) including those of healthy and 10 
osteogenesis imperfecta bone (28, 29). In the absence of alterations in whole bone 11 
morphology, microarchitecture or histology, this nano-scale alteration in bone tissue 12 
properties may be an important determinant of the loss of bone mechanical strength  13 
(14, 30). Loss of mineral elastic modulus (and corresponding loss of stiffness) may 14 
account for the decrease in compression strength over time and loss of collagen elastic 15 
modulus (and loss of flexibility and tensile strength) for the reduction in bending 16 
strength. 17 
 18 
The tissue properties of bone that determine bone strength include nature of the 19 
collagen, degree and type of collagen cross-linking, size and structure of 20 
hydroxyapatite crystals and degree of mineralization. The mineral component of bone 21 
is responsible for deformation resistance (31). In critically ill patients, circulating 22 
serum calcium has been observed to be associated with loss of bone mineral density 23 
acutely (5) and to normalize with recovery (4). This likely represents hydroxyapatite 24 
mobilization from mineral stores to maintain normocalcaemia (32). Loss of 25 
 15 
hydroxyapatite would therefore lead to loss of mineral elastic modulus, as seen in this 1 
rodent model of sepsis. Importantly, crystallinity modulation occurs independently of 2 
bone tissue turnover (and NFκβ signaling) (30). 3 
 4 
The properties of collagen fibers in bone tissue determine energy absorption, an 5 
important component of fracture resistance (33).  A recent summary of bone turnover 6 
marker studies in critical illness (34) demonstrated the consistent increase in urinary 7 
markers of loss of collagen mature cross-links - pyridinoline, deoxypyridinoline and 8 
collagen type 1 N-Telopeptide (4, 35-39). Loss of collagen cross-link formation is 9 
associated with increased fracture risk in non-critical illness pathologies (40, 41). 10 
Alterations in cross-link formation would not be visible on histological analysis, 11 
explaining the lack of changes seen. The end result of loss of these essential 12 
intermolecular and interfibrillar cross-links, with likely associated altered collagen 13 
fibre orientation (40), would be both a weakening of the extracellular matrix, leading 14 
to reduced bending strength (42), and reduced elastic modulus, despite unchanged 15 
bone mass (43). 16 
 17 
Trabecular bone has a greater sensitivity to both processes than cortical bone (44, 45), 18 
leading to functional differences seen between the femoral neck and shaft in our 19 
study. Fractures of the femoral head constitute a major personal and public health 20 
issue and the loss of bone strength seen offers further biological plausibility to the 21 
observed acute and long-term increase in fracture risk described in survivors of 22 
critical illness (3-5). 23 
 24 
 25 
 16 
Clinical Implications 1 
These data answer questions raised following Orford’s seminal description of bone 2 
loss in critical illness and its population level implications (3, 4). The rodents were not 3 
exposed to glucocorticoids or sedation, yet both mineral and elastic modulus 4 
decreased leading to a significant decrease in force needed to fracture.  5 
 6 
The mechanism of increased bone fragility seems then to be the result of altered 7 
biochemical properties of bone, as opposed to bone turnover driven loss of 8 
mineralization. Thus, modulation of osteoclastogenesis e.g.(inhibition of Receptor 9 
Activator for Nuclear Factor Kappa Beta) or osteoblastogeneisis (e.g. activation of 10 
Transforming Growth Factor Beta) seems less likely to be effective mitigation 11 
strategies. However, our data suggests that either bispohosphonate therapy (46) or 12 
calcium normalization (47), to minimize hydroxyapatite mobilization, may be 13 
appropriate interventions. In addition, early mobilization and resistance exercise is 14 
likely to be of benefit in the clinical setting, increasing bone strength via alterations in 15 
biomechanical properties (48), specifically collagen network organization and 16 
deformation resistance, as opposed to increasing bone mineral density (49). Lastly, for 17 
critical care survivors, smoking cessation therapy may have a specific role in bone 18 
health (50). 19 
 20 
Limitations 21 
Our study does have important limitations to consider. Extrapolation of rodent data to 22 
humans cannot always be done with confidence. However, biological studies on bone 23 
metabolism are challenging in humans, more so in the critical care setting. We thus 24 
limited our research question to that of the fundamental bone biological response to a 25 
 17 
septic insult. The CLP model used had a 0% rate of mortality, unlike the 55% 1 
reported in 50% caecal ligation studiess7 (17).. Therefore, this model is more likely to 2 
represent a mild/moderate form of critical illness. Models with higher mortality and 3 
end-organ damage (perhaps more representative of the higher acuity spectrum of 4 
critical illness) may demonstrate greater loss of elastic modulus and bone strength. 5 
Our animals were sacrificed at 96 hours, and it is possible insufficient time elapsed to 6 
accumulate changes in BMD or microarchitecture. However, rodent metabolic and 7 
muscle changes can be detected within this time frame (51)8, and our hypothesis is 8 
focused on identifying bone changes in early critical illness, where interventions 9 
could modulate bone health in survivors. We did not measure circulating collagen 10 
cross-link markers in the model, as this had been well described in humans, and our 11 
focus was on altered biomechanical properties and mechanisms of such alterations. 12 
Neither did we measure markers of advanced glycation end products which may 13 
represent either Acute Lung Injury (52) or increased post-transcriptional modification 14 
of new collagen fibres (44, 53, 54). Future directions for animal model work might 15 
include exploration of therapies to modulate inorganic matrix mobilization and loss of 16 
collagen cross-links. 17 
 18 
Despite the lower acuity and limited time frame, differences in elastic modulus and 19 
bone strength were demonstrated. Whilst no formal power calculation was performed, 20 
AFM scanning microscopy comparing bone stiffness in wild-type mice to those with 21 
osteogenesis imperfecta, has detected significant differences using a sample size of 2 22 
(28)6. We expected a larger standard deviation in our CLP group, therefore a larger 23 
sample size was selected, consistent with other animal publications in critical illness 24 
(55-57)1-3. Despite this, in humans, patchy myonecrosis has been seen affecting 25 
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 18 
different areas of muscle (58)- if the same were true for bone, histological and 1 
immunostaining data reported in this manuscript may be at risk of a Type II error. 2 
Our data suggest the need for larger studies on animal models (induced with a higher 3 
acuity of critical illness) or human subjects where sustainable interventions can be 4 
additionally be assessed. 5 
 6 
In conclusion, femoral neck strength is reduced in a rodent model of sepsis, with 7 
associated decreases in both collagen and mineral modulus. The mechanism of this 8 
phenomena is likely to be altered biomechanical properties instead of increased bone 9 
turnover. 10 
 11 
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Figure 1 16 
Femur mechanical strength at neck (A) and shaft of femur (B). Compressive and 17 
bending strength at the neck of femur is also shown (C and D, respectively). *Denotes 18 
data is significantly different from sham control subjects (p<0.05). †Cecal ligation 19 
and puncture. N=Newtons 20 
 21 
Figure 2 22 
(A) Collagen elastic modulus for sham, CLP(24) and CLP(96) groups. (B)  Mineral  23 
elastic modulus for sham, CLP(24) and CLP(96) groups. *Denotes data is 24 
Formatted: Font: (Default) Times New Roman, 12 pt
 19 
significantly different from sham control subjects (p<0.05). †Cecal ligation and 1 
puncture.  2 
 3 
Figure 3 4 
Representative images from multi-frequency scanning probe microscopy (SPM) and 5 
microCT reconstruction. Multi-frequency SPM was used to image collagen (A) and 6 
mineral (B) elastic modulus. MicroCT images were analysed in coronal (C) and 7 
transverse (D) views. 8 
 9 
Figure 4 10 
Representative histology images showing results of hemotoxylin and eosin (H&E) 11 
staining, as well as staining for collagen (Masson’s trichrome stain) and elastin 12 
(Verhoeff stain). Scale bar is 100μM. 13 
 14 
Figure 5 15 
Immunohistochemistry images using antibody staining for Chemokine Receptor type 16 
4 (CXCR4), Nuclear Factor Kappa Beta (NF-κB)and Tartarate Resistant Acid 17 
Phosphatase (TRAP) at the femoral neck. Scale bar is 100μM. 18 
 19 
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Abstract 1 
Objectives: Survivors of critical illness have an increased incidence of bone fractures. 2 
However, early changes in bone strength, and their relationship to structural changes, 3 
have not been described. We aimed to characterize early changes in bone functional 4 
properties in critical illness and their relationship to changes in bone structure, using a 5 
sepsis rodent model.   6 
Design: Experimental Study 7 
Setting: Animal Research Laboratory 8 
Subjects: Adult Sprague-Dawley rats 9 
Interventions: Forty Sprague-Dawley rats were randomised to cecal ligation and 10 
puncture (CLP) or sham surgery. Twenty rodents (10 CLP, 10 sham) were sacrificed 11 
at 24 hours, and 20 more at 96 hours. 12 
Measurements and main results: Femoral bones were harvested for strength testing, 13 
microCT imaging, histological analysis, and multi-frequency scanning probe 14 
microscopy (SPM). Fracture loads at the femoral neck were significantly reduced for 15 
CLP-exposed rodents at 24 hours (83.39±10.1N vs. 103.1±17.6N; p=0.014) and 96 16 
hours (81.60 ±14.2N vs. 95.66±14.3N; p=0.047). Using multi-frequency SPM, 17 
collagen elastic modulus was lower in CLP-exposed rats at 24 hours (1.37±0.2GPa vs. 18 
6.13±0.3GPa; p=0.001) and 96 hours (5.57±0.5GPa vs. 6.13±0.3GPa; p=0.006). Bone 19 
mineral elastic modulus was similar at 24 hours, but reduced in CLP-exposed rodents 20 
at 96 hours (75.34±13.2GPa vs. 134.4± 8.2GPa; p<0.001). There were no bone 21 
architectural or Bone Mineral Density differences by microCT. Similarly, histological 22 
analysis demonstrated no difference in collagen and, elastin staining, and Chemokine 23 
Receptor type 4, Nuclear Factor Kappa Beta and Tartarate Resistant Acid Phosphatase 24 
immunostaining.  25 
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 4 
Conclusions: In a rodent sepsis model, trabecular bone strength is functionally 1 
reduced within 24 hours and is associated with a reduction in collagen and mineral 2 
elastic modulus. This is likely to be the result of altered biomechanical properties, 3 
rather than increased bone mineral turnover. These data offer both mechanistic 4 
insights and may potential guide development of therapeutic interventions. 5 
  6 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 5 
INTRODUCTION 1 
Intensive care unit (ICU) survivors suffer from a variety of cognitive, neurological 2 
and physical impairments, which persist beyond acute care hospitalization and have 3 
been described as the “Post-Intensive Care Syndrome” (PICS) (1).  Bone health is 4 
likely to be an important component of PICS (2), and population studies have 5 
demonstrated a higher incidence of bone fractures in patients discharged from ICU 6 
(3). Subsequent studies, seeking mechanistic explanations, have demonstrated 7 
reduced bone mineral density (BMD) in ICU survivors (4, 5). However, it remains 8 
unclear whether the observed BMD changes, and increased fracture incidence, result 9 
from the direct effects of critical illness, prolonged immobility, or both (6). 10 
 11 
Although it is clearly established that prolonged immobility contributes to much 12 
neuromuscular morbidity in ICU survivors (7, 8), it is also apparent that metabolic 13 
derangements and cytokinaemia in early critical illness play a pivotal role (9, 10). 14 
Similarly, critically ill patients are exposed to a variety of insults that may rapidly 15 
compromise bone structure and composition, such as inflammation, acidaemia, 16 
vitamin D deficiency, corticosteroid use and hypoxia (5). These adverse stimuli may 17 
result in structural changes, or alterations in bone turnover mediated by upregulation 18 
of pathways affecting osteoblastogenesis (11) or osteclastogenesis (12), or a 19 
combination. Therefore, bone health during, or following, critical illness may be the 20 
result of a number of factors, and complete understanding is likely to include 21 
mechanisms other than accumulated loss of BMD. 22 
 23 
Factors beyond BMD certainly influence bone strength and susceptibility to fracture 24 
(13). Indeed, bone displays a hierarchical organization in its structure and 25 
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 6 
composition, ranging from macroscopic to molecular scales. Other, important, 1 
components of bone morphology influencing bone strength include bone size, cortical 2 
thickness and moment of inertia (14). In addition to whole bone morphology, bone 3 
microarchitecture, such as trabeculae shape and cortical porosity, as well as tissue 4 
properties, including collagen cross-linking and hydration, play important roles in 5 
bone strength. As a result, qualitative changes in bone strength and mechanical 6 
properties, independent of BMD, are well recognized (14).  7 
 8 
We hypothesized that critical illness results in early, functionally significant, changes 9 
in bone strength. Since invasive bone studies are not feasible in critically ill patients 10 
(15), we used a rodent model of sepsis to investigate the effects of systemic sepsis and 11 
inflammation on mechanical bone strength; nearly 40% of critically ill patients 12 
admitted to the intensive care unit (ICU) are affected by sepsis (16). In addition, we 13 
conducted a histomorphometric analysis to identify macro- and microscopic 14 
perturbations  that may offer mechanistic insight. 15 
 16 
METHODS 17 
Expanded methods available in online supplement. 18 
Rat sepsis model 19 
After obtaining Institutional Animal Care and Use Committee approval, 40 male 20 
Sprague-Dawley rats were randomized to receive cecal ligation and puncture (CLP) 21 
or sham surgery. In CLP rodents, 50% of the cecum was ligated and the anterior and 22 
posterior walls puncture with an 18G needle in a single pass  (17). In sham rodents, 23 
cecum was mobilized and replaced. Following surgery, rats were given subcutaneous 24 
fluid and analgesia and returned to individual cages with food ad libitum. After 24 25 
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 7 
and 96 hours, 10 rats in each group were euthanized with carbon dioxide inhalation 1 
and femur bones harvested. Non-invasive imaging was performed prior to strength 2 
testing. 3 
 4 
Bone mechanical testing 5 
Prior to testing biomechanical properties, bone dimensions were measured used a 6 
Vernier calliper. 7 
 8 
Three-point bending test: To measure cortical bone biomechanical properties, the 9 
right femur underwent a 3-point bending analysis. Each bone sample was placed 10 
horizontally on two transverse supports (span length (L) 17mm) with the anterior 11 
surface facing up. Load was applied perpendicularly to the bone till fracture at a 12 
constant rate of 5mm/min, using a materials testing machine, Instron-5543 (Instron 13 
Corp, Canton MA, USA). The parameters measured were load at break (N), Young’s 14 
modulus (MPa), flexure stress at maximum load (MPa) and flexure strain (extension) 15 
at maximum load (mm/mm) normalized to outer thickness of bone.    16 
 17 
Femoral neck break: To measure trabecular bone biomechanical properties, the femur 18 
underwent a femur neck break analysis. Following the 3-point bending test, samples 19 
were potted using dental cement and the length of neck and angle (Radian) measured. 20 
Samples were clamped down and a vertical load, using a flat-surface arrow-head 21 
cylinder (Instron 5543, Instron Corp, Canton MA, USA), was applied at the top of the 22 
femoral head parallel to the axis of its diaphysis at a constant rate of 5mm/min till 23 
fracture. Parameters measured were maximum Load (N), Young’s modulus (N/mm), 24 
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 8 
compression component (N), bending component (N) and bending momentum (N-1 
mm). 2 
 3 
Assessment of bone nano-mechanics  4 
Femurs were cleaned, sectioned, air dried, embedded in epoxy resin, mechanically 5 
polished and placed on microscope slides. AM-FM (amplitude modulation-frequency 6 
modulation) multi-frequency scanning probe microscopy (SPM)  was then performed 7 
(18).  8 
 9 
An oscillating sharpened probe (connected to a cantilever) was moved over the 10 
sample surface. Bone surface topography was mapped by cantilever movement, with 11 
the spring-like action of the cantilever allowing force measurements to be performed 12 
(19). The SPM probe was excited at two eigen-frequencies. The first eigenmode 13 
amplitude was used to image surface topography and the second eigenmode resonant 14 
frequency shift was used to map contact stiffness (20). Twenty measurements were 15 
taken from each bone sample (10 collagen, 10 mineral) with the average presented as 16 
a single data point for modulus in each sample.  17 
 18 
Micro-computed tomography measurements 19 
Femurs were scanned ex vivo using a Quantum GX micro-computerised tomography 20 
(microCT) imaging system (PerkinElmer, Waltham, Massachusetts, United States). 21 
Images were analysed at 3 locations, both at the shaft and neck, for bone volume/total 22 
volume (%), trabecular thickness (mm), trabecular separation (mm), connectivity 23 
density (mm-3), degree of anisotropy (DA) and bone mineral density, (BMD) (g/mm3) 24 
using BoneJ software (21). 25 
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 1 
Bone histomorphometry 2 
Bones were measured using a Vernier caliper and then prepared for histological 3 
staining. Slides were stained with hemotoxylin and eosin, Masson’s trichrome stain 4 
(for collagen) and Verhoeff stain (for elastin). The total number of osteoblasts within 5 
a specified area on either side of the fracture was manually counted and a proportion 6 
checked by an independent blinded histopathologist. Verhoeff and Masson trichrome 7 
stained areas were analyzed using ImageJ (22) and results expressed as a percentage 8 
of total bone area. 9 
 10 
Immunohistochemistry was performed on deparaffinized bone sections using 11 
the appropriate primary and secondary antibodies; tartrate-resistant acid 12 
phosphatase (TRAP) [ab58008] and Cysteine (C)-X-C motif chemokine receptor 13 
4 (CXCR4) [ab124824] (Abcam, Cambridge, Massachusetts, USA); Nuclear Factor 14 
Kappa Beta (NF-κB) [#8242] (Cell Signaling, Denver, Massachusetts, USA). 15 
Analysis was performed on tissue sections to quantify the number of positively 16 
stained cells per region of interest or per bone section using ImageJ  (22). 17 
 18 
Statistical analysis 19 
Data are presented as mean (± standard deviation) or median (interquartile range) 20 
where appropriate. Differences were analyzed using one-way ANOVA with post hoc 21 
Bonferroni or Student’s t-test for parametric data and Mann Whitney U test for non-22 
parametric data. A p value <0.05 was considered significant. Levene’s statistical test 23 
was used to compare distribution (standard deviation) data of elastic moduli. 24 
 25 
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RESULTS 1 
All forty rats survived to the end of the protocol. The weight at the time of surgery 2 
was similar in all four groups (300 - 350g); weight loss between both groups was not 3 
significantly different at 24 hours, but percentage weight loss was significantly greater 4 
in the CLP-exposed group at 96 hours (3.8% vs. 12.8% p < 0.01), as expected 5 
(Supplemental Digital Content-Table 1). 6 
 7 
Mechanical Bone Strength 8 
Femoral neck: The maximum load required to fracture the femoral neck was 20% less 9 
for CLP-exposed rats relative to sham control after 24 hours (83.39±10.1 Newton (N) 10 
vs. 103.1±17.6N; n=8; p=0.014). This difference persisted at 96 hours (81.60 ±14.2N 11 
vs. 95.66±14.3N; n=9; P=0.047) (Figure 1A). Compressive strength was decreased in 12 
CLP-exposed rats at 24 hours, compared to sham (44.32±5.7N vs. 58.75±14.8N; n=8; 13 
p=0.021); a similar difference was observed at 96 hours although not statistically 14 
significant (45.8±12.1N vs. 55.8±8.2N; n=8; p=0.068) (Figure 1C). Bending strength 15 
differed in CLP-exposed rats, compared to sham, although statistical significance was 16 
achieved only at 96 hours (at 24 hours: 70.49±9.6N vs. 83.87±15.9N; n=8; p=0.057; 17 
at 96 hours: 66.89±12.3N vs. 80.2±13.3N; n=8; p=0.038) (Figure 1D). 18 
 19 
Femoral shaft: There was no significant difference in the maximum load required to 20 
fracture the femoral shaft of CLP-exposed rats when compared to sham, at either 24 21 
hours (118.32±18.2N vs. 119.78±23.9N; n=10; p=0.88) or 96 hours (116.81±27.3N 22 
vs. 128.75±28.5.9N; n=8; p=0.379) (Figure 1B).  23 
 24 
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Bone nano-mechanics with multi-frequency scanning probe microscopy 1 
Collagen elastic modulus was lower after 24 hours in CLP rats compared to sham 2 
(1.37±0.2 Gigapascals (GPa) vs. 6.13±0.3 GPa; n=8; p=0.001). Despite partial 3 
recovery at 96 hours, it remained lower than controls (5.57±0.5 GPa vs. 6.13±0.3 4 
GPa; n=8; p=0.006) (Figure 2A). In contrast, bone mineral elastic modulus was 5 
similar in both groups at 24 hours (128.7±8.1 GPa vs. 134.4±8.2 GPa; n=8; p=0.131), 6 
but reduced in CLP-exposed rats at 96 hours (75.34±13.2 GPa vs. 134.4±8.2 GPa; 7 
n=8; p<0.001) (Figure 2B). Representative images are shown in Figure 3A and 3B. 8 
The distributions of elastic moduli measurements for each group are shown in Figure 9 
4. Collagen elastic modulus distribution was higher at 96 hours compared to sham 10 
(Levene statistic 238.6, p<0.001; Supplementary Digital Content Figure 1A) implying 11 
impaired collagen quality recovery. The Mineral elastic modulus was similarly 12 
affected at 96 hours (Levene statistic 150.5; p<0001; Supplementary Digital Content 13 
Figure 1B). 14 
 15 
Whole bone geometry 16 
As shown in Supplemental Digital Content Table 2, there was no difference in cortical 17 
thickness, neck and shaft diameter or neck length between CLP and sham groups at 18 
24 and 96 hours. 19 
 20 
Bone mineral density and microarchitecture  21 
Micro-CT reconstruction and histomorphometric analysis of the femoral neck did not 22 
reveal differences between CLP and sham in bone volume/total volume ratio, 23 
trabecular thickness and separation, connectivity density, degree of anisotropy and 24 
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bone mineral density at 24 or 96 hours (all p>0.10, Table S1). Representative images 1 
are shown in Figures 3C and 3D. 2 
 3 
Histological analysis 4 
Histologic sections demonstrated no difference in epiphyseal growth plate thickness 5 
and cellular organization between CLP-exposed and sham groups at 24 hours 6 
(118±7µM vs. 125±14µM; p=0.425) or 96 hours (115±22µM vs. 102±6µM; 7 
p=0.289). Osteoblast numbers did not differ in CLP-exposed rodents at 24 hours 8 
(2.1±0.5 vs. 2.2±0.8; p=0.758) or at 96 hours (1.8±0.4 vs. 1.7±0.6; p=0.684). 9 
Similarly, no differences were seen in TRAP staining (marker of osteoclastic 10 
differentiation) at 24 hours (17.4±6.6% vs. 16.2±4.2; p=0.803) and at 96 hours 11 
(19.9±2.5% vs. 15.9±8.0%; p=0.456). No significant differences were seen between 12 
both groups in percentage of elastin staining at 24 hours (12.9±5.5% vs. 29.1±21.0%; 13 
p=0.185) or 96 hours (34.0±22.8 vs. 14.4±4.4%; p=0. 143), and percentage of 14 
collagen staining (75.6±11.5% vs. 70.1±17% %; p=0.611) and (70.5±15.0% vs. 75.0 15 
±10.9%; p=0.638). Representative images are shown in Figure 4. 16 
 17 
CXCR4 staining did not differ between sham and CLP at 24 hours (15.2±10.3% vs. 18 
11.6±5.0%; p=0.612) or 96 hours (16.5±11.9% vs. 9.7±4.7%; p=0.407) and similarly 19 
with NF-κB at 24 hours (2.2±1.4% vs. 3.3±1.1%; p=0.325) and at 96 hours (5.1±3.3% 20 
vs. 6.9±3.9%; p=0.559). Representative images are shown in Figure 5. 21 
 22 
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 13 
DISCUSSION 1 
 2 
In this study, we set out to establish the nature of bone response to critical illness, and 3 
the related functional consequences. In the CLP-exposed rodents there was evidence 4 
of early functional changes, compared to sham surgery controls, with a lower 5 
maximum load required to fracture the femoral neck at 24 hours. Multi-frequency 6 
SPM demonstrated a rapid decrease in collagen elastic modulus at 24 hours, which 7 
partially recovered at 96 hours. Mineral elastic modulus was preserved at 24 hours, 8 
but decreased significantly at 96 hours. 9 
 10 
Bone architecture and BMD remained unchanged, as determined by micro-CT. 11 
Similarly, histological analysis revealed no differences in bone structure or collagen 12 
and elastin content. The observed decrease in bone strength was not accompanied by 13 
any change in CXCR4 or NFκβ expression, or disruption in epiphyseal growth plate 14 
organization, osteoblast or osteoclast morphology or quantity and TRAP activity. The 15 
CXCR4 pathway plays a crucial role in the osteogenic differentiation of mesenchymal 16 
progenitors, and a disruption in its expression or function results in bone epiphyseal 17 
growth plate disorganization and abnormal steoblasts development (23).  The 18 
transcription factor NFκβ is a crucial mediator of inflammatory responses, and has 19 
been implicated in promoting differentiation of myeloid cells into osteoclasts to 20 
exacerbate bone resorption, and to impair bone formation by disrupting osteoblast 21 
formation and function (24).  22 
 23 
The observation of early functional changes to bone strength, in the absence of 24 
macroscopic or microscopic changes, reflect the complex organization of bone 25 
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structure and the many factors contributing to bone strength. Alterations in matrix 1 
composition leading to loss of elastic modulus may effect bone strength, without 2 
changing BMD (25), but were excluded by histological analysis.  Similarly, the lack 3 
of significant pertubations in osteoblast and osteoclast quantity and epiphyseal growth 4 
plate thickness and cellular organization, does not support increased bone turnover as 5 
an explanation for the early reduction in bone strength we observed. 6 
 7 
We used multi-frequency scanning probe microscopy (SPM) to analyze changes in 8 
bone tissue properties. This technique has been used to study the nano-mechanical 9 
properties of a range of biological tissues (26-28) including those of healthy and 10 
osteogenesis imperfecta bone (28, 29). In the absence of alterations in whole bone 11 
morphology, microarchitecture or histology, this nano-scale alteration in bone tissue 12 
properties may be an important determinant of the loss of bone mechanical strength  13 
(14, 30). Loss of mineral elastic modulus (and corresponding loss of stiffness) may 14 
account for the decrease in compression strength over time and loss of collagen elastic 15 
modulus (and loss of flexibility and tensile strength) for the reduction in bending 16 
strength. 17 
 18 
The tissue properties of bone that determine bone strength include nature of the 19 
collagen, degree and type of collagen cross-linking, size and structure of 20 
hydroxyapatite crystals and degree of mineralization. The mineral component of bone 21 
is responsible for deformation resistance (31). In critically ill patients, circulating 22 
serum calcium has been observed to be associated with loss of bone mineral density 23 
acutely (5) and to normalize with recovery (4). This likely represents hydroxyapatite 24 
mobilization from mineral stores to maintain normocalcaemia (32). Loss of 25 
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 15 
hydroxyapatite would therefore lead to loss of mineral elastic modulus, as seen in this 1 
rodent model of sepsis. Importantly, crystallinity modulation occurs independently of 2 
bone tissue turnover (and NFκβ signaling) (30). 3 
 4 
The properties of collagen fibers in bone tissue determine energy absorption, an 5 
important component of fracture resistance (33).  A recent summary of bone turnover 6 
marker studies in critical illness (34) demonstrated the consistent increase in urinary 7 
markers of loss of collagen mature cross-links - pyridinoline, deoxypyridinoline and 8 
collagen type 1 N-Telopeptide (4, 35-39). Loss of collagen cross-link formation is 9 
associated with increased fracture risk in non-critical illness pathologies (40, 41). 10 
Alterations in cross-link formation would not be visible on histological analysis, 11 
explaining the lack of changes seen. The end result of loss of these essential 12 
intermolecular and interfibrillar cross-links, with likely associated altered collagen 13 
fibre orientation (40), would be both a weakening of the extracellular matrix, leading 14 
to reduced bending strength (42), and reduced elastic modulus, despite unchanged 15 
bone mass (43). 16 
 17 
Trabecular bone has a greater sensitivity to both processes than cortical bone (44, 45), 18 
leading to functional differences seen between the femoral neck and shaft in our 19 
study. Fractures of the femoral head constitute a major personal and public health 20 
issue and the loss of bone strength seen offers further biological plausibility to the 21 
observed acute and long-term increase in fracture risk described in survivors of 22 
critical illness (3-5). 23 
 24 
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Clinical Implications 1 
These data answer questions raised following Orford’s seminal description of bone 2 
loss in critical illness and its population level implications (3, 4). The rodents were not 3 
exposed to glucocorticoids or sedation, yet both mineral and elastic modulus 4 
decreased leading to a significant decrease in force needed to fracture.  5 
 6 
The mechanism of increased bone fragility seems then to be the result of altered 7 
biochemical properties of bone, as opposed to bone turnover driven loss of 8 
mineralization. Thus, modulation of osteoclastogenesis e.g.(inhibition of Receptor 9 
Activator for Nuclear Factor Kappa Beta) or osteoblastogeneisis (e.g. activation of 10 
Transforming Growth Factor Beta) seems less likely to be effective mitigation 11 
strategies. However, our data suggests that either bispohosphonate therapy (46) or 12 
calcium normalization (47), to minimize hydroxyapatite mobilization, may be 13 
appropriate interventions. In addition, early mobilization and resistance exercise is 14 
likely to be of benefit in the clinical setting, increasing bone strength via alterations in 15 
biomechanical properties (48), specifically collagen network organization and 16 
deformation resistance, as opposed to increasing bone mineral density (49). Lastly, for 17 
critical care survivors, smoking cessation therapy may have a specific role in bone 18 
health (50). 19 
 20 
Limitations 21 
Our study does have important limitations to consider. Extrapolation of rodent data to 22 
humans cannot always be done with confidence. However, biological studies on bone 23 
metabolism are challenging in humans, more so in the critical care setting. We thus 24 
limited our research question to that of the fundamental bone biological response to a 25 
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 17 
septic insult. The CLP model used had a 0% rate of mortality, unlike the 55% 1 
reported in 50% caecal ligation studies (17). Therefore, this model is more likely to 2 
represent a mild/moderate form of critical illness. Models with higher mortality and 3 
end-organ damage (perhaps more representative of the higher acuity spectrum of 4 
critical illness) may demonstrate greater loss of elastic modulus and bone strength. 5 
Our animals were sacrificed at 96 hours, and it is possible insufficient time elapsed to 6 
accumulate changes in BMD or microarchitecture. However, rodent metabolic and 7 
muscle changes can be detected within this time frame (51), and our hypothesis is 8 
focused on identifying bone changes in early critical illness, where interventions 9 
could modulate bone health in survivors. We did not measure circulating collagen 10 
cross-link markers in the model, as this had been well described in humans, and our 11 
focus was on altered biomechanical properties and mechanisms of such alterations. 12 
Neither did we measure markers of advanced glycation end products which may 13 
represent either Acute Lung Injury (52) or increased post-transcriptional modification 14 
of new collagen fibres (44, 53, 54). Future directions for animal model work might 15 
include exploration of therapies to modulate inorganic matrix mobilization and loss of 16 
collagen cross-links. 17 
 18 
Despite the lower acuity and limited time frame, differences in elastic modulus and 19 
bone strength were demonstrated. Whilst no formal power calculation was performed, 20 
AFM scanning microscopy comparing bone stiffness in wild-type mice to those with 21 
osteogenesis imperfecta, has detected significant differences using a sample size of 2 22 
(28). We expected a larger standard deviation in our CLP group, therefore a larger 23 
sample size was selected, consistent with other animal publications in critical illness 24 
(55-57). Despite this, in humans, patchy myonecrosis has been seen affecting different 25 
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areas of muscle (58)- if the same were true for bone, histological and immunostaining 1 
data reported in this manuscript may be at risk of a Type II error. Our data suggest the 2 
need for larger studies on animal models (induced with a higher acuity of critical 3 
illness) or human subjects where sustainable interventions can be additionally be 4 
assessed. 5 
 6 
In conclusion, femoral neck strength is reduced in a rodent model of sepsis, with 7 
associated decreases in both collagen and mineral modulus. The mechanism of this 8 
phenomena is likely to be altered biomechanical properties instead of increased bone 9 
turnover. 10 
 11 
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Figure 1 16 
Femur mechanical strength at neck (A) and shaft of femur (B). Compressive and 17 
bending strength at the neck of femur is also shown (C and D, respectively). *Denotes 18 
data is significantly different from sham control subjects (p<0.05). †Cecal ligation 19 
and puncture. N=Newtons 20 
 21 
Figure 2 22 
(A) Collagen elastic modulus for sham, CLP(24) and CLP(96) groups. (B)  Mineral  23 
elastic modulus for sham, CLP(24) and CLP(96) groups. *Denotes data is 24 
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 19 
significantly different from sham control subjects (p<0.05). †Cecal ligation and 1 
puncture.  2 
 3 
Figure 3 4 
Representative images from multi-frequency scanning probe microscopy (SPM) and 5 
microCT reconstruction. Multi-frequency SPM was used to image collagen (A) and 6 
mineral (B) elastic modulus. MicroCT images were analysed in coronal (C) and 7 
transverse (D) views. 8 
 9 
Figure 4 10 
Representative histology images showing results of hemotoxylin and eosin (H&E) 11 
staining, as well as staining for collagen (Masson’s trichrome stain) and elastin 12 
(Verhoeff stain). Scale bar is 100μM. 13 
 14 
Figure 5 15 
Immunohistochemistry images using antibody staining for Chemokine Receptor type 16 
4 (CXCR4), Nuclear Factor Kappa Beta (NF-κB)and Tartarate Resistant Acid 17 
Phosphatase (TRAP) at the femoral neck. Scale bar is 100μM. 18 
 19 
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